Da Silva Jorge Santos, Chief Executive Officer at MoonLake Immunotherapeutics (MLTX), sold 150,000 shares at $18.41 ($2.8M) on 2026-04-10, disclosed to the SEC on 2026-04-14.
Open-market sale of $2.8M MLTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.41 | 98,127 | $1.8M | 65.6% |
| 2 | $18.23 | 51,873 | $946K | 34.4% |
| Total | $18.35 avg | 150,000 | $2.8M | 100% |
| Filing → |
| MLTX | SELL | 2025-12-10 | $3.0M | — | Filing → |
| MLTX | SELL | 2024-02-29 | $7.1M | — | Filing → |
| MLTX | SELL | 2024-02-23 | $124K | — | Filing → |